Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit. Click here to listen.
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here.